Triptodur Kit
Product Images NDC 24338-150

12 FDA label images from Azurity Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Triptodur (NDC 24338-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Triptodur-spl-1 (Triptodur Spl 1)

Triptodur-spl-1 (Triptodur Spl 1)
Instructional diagrams showing hands preparing a syringe by pulling the plunger to draw liquid and then twisting the plunger to secure it, likely part of a medication preparation process for the TRIPTODUR kit by Azurity Pharmaceuticals, Inc.*
FDA Label Image

Triptodur-spl-2 (Triptodur Spl 2)

Triptodur-spl-2 (Triptodur Spl 2)
An instructional illustration showing a hand holding a vial or syringe component, with arrows indicating to push down and twist the top portion. This diagram appears to demonstrate a step in preparing or activating a medication kit, specifically for TRIPTODUR (triptorelin) kit by Azurity Pharmaceuticals.*
FDA Label Image

Triptodur-spl-3 (Triptodur Spl 3)

Triptodur-spl-3 (Triptodur Spl 3)
An instructional black-and-white line drawing showing hands preparing a syringe by attaching or removing a needle cap. One hand is holding the syringe barrel while the other hand pulls the needle cap upward and away from the syringe.*
FDA Label Image

Triptodur-spl-4 (Triptodur Spl 4)

Triptodur-spl-4 (Triptodur Spl 4)
An instructional diagram showing two hands preparing an injection. One hand holds a syringe vertically above a vial or container, with an arrow indicating the syringe plunger should be pushed down into the vial held by the other hand.*
FDA Label Image

Triptodur-spl-5 (Triptodur Spl 5)

Triptodur-spl-5 (Triptodur Spl 5)
An instructional diagram showing a hand holding a syringe with an arrow indicating an up-and-down shaking motion. A clock icon indicates to shake the syringe for 30 to 60 seconds, illustrating preparation steps for using the medication.*
FDA Label Image

Triptodur-spl-6 (Triptodur Spl 6)

Triptodur-spl-6 (Triptodur Spl 6)
An instructional illustration showing two panels, each depicting a hand drawing liquid from a vial into a syringe. Each hand grips the syringe vertically with the needle inserted into the vial, with downward arrows indicating the action of pulling liquid into the syringe. This diagram appears to demonstrate proper technique for preparing an injection, likely related to the TRIPTODUR (triptorelin) kit.*
FDA Label Image

Triptodur-spl-7 (Triptodur Spl 7)

Triptodur-spl-7 (Triptodur Spl 7)
Instructional diagram showing a hand holding a pen-like device with an arrow indicating to push down and a curved arrow indicating to rotate a cap or part of the device. This likely illustrates how to prepare or use the TRIPTODUR kit injection device.*
FDA Label Image

Triptodur-spl-8 (Triptodur Spl 8)

Triptodur-spl-8 (Triptodur Spl 8)
An instructional illustration showing two hands preparing a syringe device. One hand is holding the syringe body while the other hand is twisting or pulling a component attached to the syringe tip, indicating how to unlock or remove a part of the syringe mechanism.*
FDA Label Image

Triptodur-spl-9 (Triptodur Spl 9)

Triptodur-spl-9 (Triptodur Spl 9)
An instructional illustration showing a syringe with a plunger and needle capped by a protective cover, enclosed within a circle with a diagonal slash through it, indicating that the syringe or needle should not be used or tampered with in a certain way.*
FDA Label Image

Triptodur-spl-10 (Triptodur Spl 10)

Triptodur-spl-10 (Triptodur Spl 10)
An instructional illustration showing the proper technique for injection using a syringe. One hand is holding the syringe vertically above the injection site on a finger, while the other hand steadies the finger. An arrow indicates the downward motion to administer the injection.*
FDA Label Image

Triptodur-spl-11 (Triptodur Spl 11)

Triptodur-spl-11 (Triptodur Spl 11)
Chemical structure of triptorelin pamoate (C23H16O6), showing the detailed molecular formula with amino acid residues and functional groups as depicted in the image.*
FDA Label Image

Triptodur-image-12 (Triptodur Spl Img12)

Triptodur-image-12 (Triptodur Spl Img12)
Packaging label for TRIPTODUR 22.5 mg kit, an extended-release injectable suspension of triptorelin for intramuscular use. The label indicates dosing every 24 weeks and includes directions that it must be administered by a healthcare professional. The kit contains one single-dose vial, one pre-filled syringe of diluent, and two 21-gauge needles. Labeler is Azurity Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.